Our top pick for
Beginners

TransAtlantic Petroleum Ltd is an oil & gas e&p business based in the US. TransAtlantic Petroleum shares (TAT) are listed on the NYSE MKT and all prices are listed in US Dollars. TransAtlantic Petroleum employs 147 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | $0.00 - $0.00 |
---|---|
50-day moving average | $0.26 |
200-day moving average | $0.26 |
Wall St. target price | $1.89 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.12 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing TransAtlantic Petroleum stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TransAtlantic Petroleum's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
TransAtlantic Petroleum's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.8 million.
The EBITDA is a measure of a TransAtlantic Petroleum's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $40 million |
---|---|
Gross profit TTM | $51.2 million |
Return on assets TTM | -7.65% |
Return on equity TTM | -90.35% |
Profit margin | -93.05% |
Book value | $0.12 |
Market capitalisation | $18.6 million |
TTM: trailing 12 months
We're not expecting TransAtlantic Petroleum to pay a dividend over the next 12 months.
TransAtlantic Petroleum's shares were split on a 1:10 basis on 6 March 2014. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TransAtlantic Petroleum shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for TransAtlantic Petroleum shares which in turn could have impacted TransAtlantic Petroleum's share price.
Over the last 12 months, TransAtlantic Petroleum's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while TransAtlantic Petroleum's is 1.3207. This would suggest that TransAtlantic Petroleum's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TransAtlantic Petroleum Ltd. , an oil and natural gas company, engages in the acquisition, exploration, development, and production of oil and natural gas properties in Turkey and Bulgaria. As of December 31, 2019, it had interests in 4 onshore exploration licenses and 20 onshore production leases covering an area of 436,388 net acres with a total net proved reserves of 10,259 thousand barrels of oil and 2,466 million cubic feet of natural gas located in Turkey, as well as a production concession covering an area of approximately 162,800 net undeveloped acres located in Bulgaria. The company was incorporated in 1985 and is based in Addison, Texas. As of December 18, 2020, TransAtlantic Petroleum Ltd. was taken private. .
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.